EFFECTIVENESS OF AUTOLOGUS INJECTION PLATELET RICH PLASMA IN MANAGEMENT OF LATERAL EPICONDYLITIS AND TO MEASURE THE OUTCOMES IN A SHORT TERM FOLLOW UP

Introduction: An inflammatory disorder known as lateral epicondylitis develops where the common extensor tendon of the forearm originates over the lateral epicondyle. It is the most prevalent chronic, debilitating, and painful elbow condition. 1 to 3 percent of the overall population experiences symptoms. Aim And Objectives: to assess the results of a brief follow-up study after a single dose of autologous platelet-rich plasma injection for the treatment of lateral epicondylitis. Materials And Methods:This is a prospective study of about 25 patients includes 17 females and 8 males who were diagnosed as lateral epicondylitis. Platelet rich plasma group was injected with 3-4 ml platelet rich plasma, using a “peppering” technique in a clock wise manner to better cover the affected area of lateral epicondyle. Results: All the relevant data were analysed. The average Visual Analogue Scale (VAS) and Disabilities of the Arm, Shoulder and Hand (DASH) scores of pre injection, 4th week, 8th week and 12th week post injection Discussion: Currently, platelet rich plasma (PRP) is considered as the optimal biological component produced from autologous blood. In addition, platelet rich plasma has high antimicrobial potency and this property may prevent infections. Conclusion: Pain and decreased functional activities in lateral epicondylitis are significantly improved by a single autologous platelet-rich plasma injection.